Anti-TNFα therapy in IBD alters brain activity reflecting visceral sensory function and cognitive-affective biases.
Marcus A GrayChe-Yung ChaoHeidi M StaudacherNatasha A KoloskyNicholas J TalleyGerald HoltmannPublished in: PloS one (2018)
In patients with Crohn's disease, anti-TNFα administration reduces visceral sensitivity and improves implicit cognitive-affective biases linked to alterations in limbic (amygdala) function.